Globus Medical (GMED) Change in Receivables (2011 - 2026)

Globus Medical's Change in Receivables history runs 16 years deep, the most recent figure standing at $13.4 million for Q1 2026.

• Quarterly Change in Receivables rose 159.28% year-over-year to $13.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $88.2 million (up 362.52% YoY) and the FY2025 annual result came in at $52.2 million, down 33.15% from the prior year.
• Change in Receivables was $13.4 million for Q1 2026 at Globus Medical, down from $64.2 million in the prior quarter.
• Across five years, Change in Receivables topped out at $87.8 million in Q2 2024 and bottomed at -$23.7 million in Q3 2024.
• A 5-year average of $14.4 million and a median of $9.9 million in 2023 frame the typical range for Change in Receivables.
• Annual changes were most pronounced in 2023 — Change in Receivables soared 510.97% — and 2024, when it sank 371.47%.
• Globus Medical's Change in Receivables stood at $4.6 million in 2022, then soared by 179.15% to $13.0 million in 2023, then slumped by 273.47% to -$22.5 million in 2024, then jumped by 385.34% to $64.2 million in 2025, then plunged by 79.11% to $13.4 million in 2026.
• Business Quant data shows GMED's Change in Receivables at $13.4 million in Q1 2026, $64.2 million in Q4 2025, and $8.4 million in Q3 2025.